APA

Chan P. S., Coupet J., Park H. C., Lai F., Hartupee D., Cervoni P., Dusza J. P., Albright J. D., Ru X., Mazandarani H., Tanikella T., Shepherd C., Ochalski L., Bailey T., Lock T. Y., Ning X., Taylor J. R. & Spinelli W. (19990310). VPA-985, a nonpeptide orally active and selective vasopressin V2 receptor antagonist. : Advances in experimental medicine and biology.

Chicago

Chan P S, Coupet J, Park H C, Lai F, Hartupee D, Cervoni P, Dusza J P, Albright J D, Ru X, Mazandarani H, Tanikella T, Shepherd C, Ochalski L, Bailey T, Lock T Y, Ning X, Taylor J R and Spinelli W. 19990310. VPA-985, a nonpeptide orally active and selective vasopressin V2 receptor antagonist. : Advances in experimental medicine and biology.

Harvard

Chan P. S., Coupet J., Park H. C., Lai F., Hartupee D., Cervoni P., Dusza J. P., Albright J. D., Ru X., Mazandarani H., Tanikella T., Shepherd C., Ochalski L., Bailey T., Lock T. Y., Ning X., Taylor J. R. and Spinelli W. (19990310). VPA-985, a nonpeptide orally active and selective vasopressin V2 receptor antagonist. : Advances in experimental medicine and biology.

MLA

Chan P S, Coupet J, Park H C, Lai F, Hartupee D, Cervoni P, Dusza J P, Albright J D, Ru X, Mazandarani H, Tanikella T, Shepherd C, Ochalski L, Bailey T, Lock T Y, Ning X, Taylor J R and Spinelli W. VPA-985, a nonpeptide orally active and selective vasopressin V2 receptor antagonist. : Advances in experimental medicine and biology. 19990310.